MATTES GLENN R. (President and CEO) purchased 100.0% of their position (10K shares) of TFF PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $71.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/16/2021ACC: 0001213900-21-048369
DirectorOfficer· President and CEO
Since Oct 2019
+10K
Net shares
Net buyer
$71.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$7.10
Trade value
$71K
% of position
100.0%
9/16/2021
10K→20K
Total
Net shares
+10K
Net value
$71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2021 | P · Purchase | +10K | $7.10 | $71K | 100.0% | 10K | 20K |
| Total | +10K | $71K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned7K
Total
7K indirect7K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 7K | Indirect |
| Total | 7K | 7K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported